- SalvaRx Group said subsidiary iOx Therapeutics, of which it owned around 57%, had issued $1m of unsecured convertible loan notes.

The funds would assist iOx to regain momentum, following a delay caused by previous manufacturing issues announced in July, the company said.

At 9:51am: [LON:SALV] Salvarx Group Plc share price was 0p at 67.5p

Story provided by